biotech
Bio-AnalystSupplement research
person

Psyllium

Selected research topic

Glucose and metabolic health

Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.

Findings from a combination study cannot be attributed to this ingredient alone.

Animal and cell findings do not establish the same effect in people.

Some findings concern patients or people with a deficiency.

Publications for this topic
17
Human comparison publications
5
Publications needing review
3

Findings in the studies

  • Body weight

    Human comparison research
    • A better result than the comparison group was reported.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      What the comparison group used was not confirmed.

      Patient group · Combination study
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Single ingredient
      Measurement time
      Not confirmed.
  • Fasting blood sugar

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • HbA1c

    Human comparison research
    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · 8 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Intervention-group pre/post HbA1c change; abstract does not provide HbA1c between-group significance
      Additional measurement information
      Primary outcome
      Measurement time
      8 weeks
    Research with unclear study subject or type
    • The study reported improvement in this measurement.
      Single ingredient · study durations varied
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: General population. Whether the research involved humans needs confirmation.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: pooled psyllium versus placebo comparison
      Additional measurement information
      Primary outcome
      Measurement time
      study durations varied
  • HOMA-IR

    • A better result than the comparison group was reported.
      Patient group · 10–12 weeks
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Human participants · Patient group
      Ingredients tested
      Unknown intervention
      How results were compared
      Results were compared between groups. · Study comparison: Added fiber interventions vs maltodextrin or crushed-wheat controls across included trials
      Additional measurement information
      Secondary outcome
      Measurement time
      10–12 weeks
Other measured outcomes (8)
  • Insulin

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • Fasting blood glucose

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Other evidence
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      Measurement time
      Not confirmed.
  • plasma glucose

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      Measurement time
      Not confirmed.
  • plasma glucose concentration

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.
      Single ingredient
      Measurement and study conditions
      Study type
      Animal study · indirect
      Study population
      This is animal research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Single ingredient
      How results were compared
      Comparison unclear
      Measurement time
      Not confirmed.
  • fasting insulin level

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient
      Measurement and study conditions
      Study type
      Systematic review
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Single ingredient
      Measurement time
      Not confirmed.
  • HOMA IR

    Research with unclear study subject or type
    • The study reported improvement in this measurement.
      Single ingredient · study durations varied
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: General population. Whether the research involved humans needs confirmation.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: pooled psyllium versus placebo comparison
      Additional measurement information
      Primary outcome
      Measurement time
      study durations varied
  • insulin and glucose responses

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      postprandial
      Measurement and study conditions
      Study type
      Review
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: review summary across beta-glucan, psyllium, and guar gum; no single-ingredient comparison
      Additional measurement information
      Biomarker
      Measurement time
      postprandial
  • Lower GIs

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Study subject not identified
      Ingredients tested
      Ingredient combination
      How results were compared
      Study comparison: formulations containing psyllium and other listed ingredients
      Additional measurement information
      Secondary outcome
      Measurement time
      Not confirmed.
Representative outcome and study details

Human studies reported between-group improvement in Body weight; while Studies with an unspecified organism reported a change with no confirmed comparison group in Body weight.

These conditions come from related studies and may not describe a single paper.

single- and combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · Includes patient groups · between-group comparison · comparator not confirmed

3 publications linked to this result

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 65.0 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 84

Papers linked to this topic 17 · distinct papers 17 · papers with a confirmed human comparison 5 · papers needing additional review 3

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Body weight: Sources represented in this measurement group: 3 · Distinct papers with human comparisons for this outcome: 1
  • Fasting blood glucose: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Fasting blood sugar: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • fasting insulin level: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • HbA1c: Sources represented in this measurement group: 3 · Distinct papers with human comparisons for this outcome: 1
  • HOMA IR: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • HOMA-IR: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • Insulin: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • insulin and glucose responses: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Lower GIs: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • plasma glucose: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • plasma glucose concentration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

Body weight

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting blood sugar

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Insulin

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

The study reported improvement in this measurement.

Meta-analysis · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HOMA IR

The study reported improvement in this measurement.

Meta-analysis · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HOMA-IR

The study reported improvement in this measurement.

Meta-analysis · Unknown intervention · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Body weight

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

2 papers · 2 measured outcomes

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting blood glucose

A change was reported, but the comparison could not be confirmed.

Other evidence · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

fasting insulin level

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

insulin and glucose responses

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Lower GIs

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma glucose

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma glucose concentration

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 2 measured outcomes

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

small bowel obstruction1 papers
Four patients experienced small bowel obstruction after oral psyllium seed husk use as a contrast agent.Human studies · Study type not identified
Intestinal obstruction1 papers
Psyllium ingestion without adequate fluids caused intestinal obstruction in a 21‑year‑old man.Human studies · Observational study